🇺🇸 FDA
Patent

US 11401513

Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

granted A61KA61K31/397A61K38/00

Quick answer

US patent 11401513 (Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use) held by Catalyst Biosciences, Inc. expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Catalyst Biosciences, Inc.
Grant date
Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
41
CPC classes
A61K, A61K31/397, A61K38/00, A61K45/06